Introduction Quality of syphilis testing is a critical component of effective STI control programs, including elimination of mother-to-child transmission of HIV and syphilis. To understand syphilis testing policies and practices in the Region of the Americas, the Pan American Health Organisation (PAHO) surveyed directors of national/regional reference and lowerlevel laboratories in its 35 member states. Methods In 2014, PAHO identified directors of national/ regional reference laboratories and a convenience sample of lower-level laboratories providing clinical diagnostic testing. An electronically-administered survey was used to collect data on tests and algorithms used, quality assurance/quality control (QA/QC) systems, and challenges faced. Results The 69 participating laboratories, representing 30 (86%) PAHO member states, were from Central America (n=22, 32%), the Caribbean (n=15, 22%), the Andean (n=16, 23%) and Southern Cone nations (n=14, 20%), and North America (n=2, 3%). Of the 69 laboratories, 41 (59%) were national or regional reference facilities and 28 (41%) were lower-level facilities (25 public and 3 private). Overall 49 (71%) laboratories (80% reference, 57% other) reported using a nationally recommended algorithm for syphilis testing, primarily a non-treponemal screening test and treponemal confirmatory test (n=35, 71%). Ten laboratories (7 reference, 3 other) used an algorithm that did not employ confirmatory testing. Twenty-eight (41%) laboratories reported using rapid tests (49% reference, 29% other). Thirty-three (48%) could provide results to clinics within 24 hours. Some type of QA/ QC program was reported by 60 (87%) laboratories (88% reference, 86% other). Of the 69 laboratories, 83% used daily controls, 64% routinely maintained equipment, 70% participated in an external QA program, and 65% used standard operating procedures. Frequently reported challenges were limited opportunities for staff training (73%), insufficient equipment (24%) and stock outs of reagents and other supplies (55%). Conclusion Many reference and clinical laboratories in the region still face challenges in ensuring quality syphilis testing. Many lack adequately trained staff, and some lack sufficient supplies for routine syphilis testing. Several have not yet adopted basic QA/QC practices needed to ensure quality testing. Less than half of the laboratories have adopted rapid testing strategies.
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Women's Health and Prevention Introduction We tested the hypothesis that vaginal microbiota influence women's susceptibility to T. vaginalis (TV) acquisition.
Methods We conducted a nested case-control study of 25 episodes of TV infection using vaginal samples collected 30-60 days prior to infection in 18 HIV-negative women and 50 incidence-density matched controls. Broad-range 16S rRNA gene PCR was used to measure total vaginal bacterial load. Deep sequencing was applied to 18 first episodes of TV infection and 36 matched controls to measure bacterial diversity (Shannon index) and species richness (Chao-1 index). Bacterium-specific quantitative PCR was performed for Lactobacillus crispatus, Prevotella amnii, Sneathia sanguinegens, Dialister species Type 2, Bacterial Vaginosis Associated Bacterium 1 (BVAB-1), and Mageeibacillus indolicus for all TV infection cases and controls. The associations between Shannon and Chao-1 indices and TV acquisition were evaluated using logistic regression. Generalised estimating equations with logit link were used to evaluate associations between TV acquisition, detection of bacterial species, and total vaginal bacterial load. women were Dutch-Caucasian, 9 used hormonal contraceptives and all were highly educated. At baseline, 8 women had lactobacilli-dominated VM (Lactobacillus crispatus (n=6), L. iners (n=1) or L. iners/L. jensenii (n=1)) and 2 women had polybacterial Gardnerella vaginalis-containing VM (GV-VM). The latter 2 women continued to have GV-VM throughout the study period. The VMs of 2 women, dominated either by L. crispatus or L. iners at baseline, shifted to GV-VM during the 2nd cycle, which persisted in the 3rd cycle. Having GV-VM was more likely in the 2nd and 3rd cycle, compared to the 1 st cycle, after adjusting for sex and menses (odds ratio (OR) =1.7 (95% CI: 0.9-3.1) and OR=2.1 (95% CI: 0.7-6.1), respectively), though not statistically significanctly so. Introduction Innovative approaches for delivery of hormonal contraception and antiretrovirals are urgently needed. Intravaginal vaginal rings are a promising strategy since they obviate the need for daily dosing, a challenge in some HIV prevention studies in sub-Saharan Africa (SSA). Changes in the vaginal microbiome associated with increased risk of bacterial vaginosis (BV) are a risk for HIV acquisition and transmission, as is pregnancy. Therefore, hormonal interventions that prevent unintended pregnancies (UIP) and promote vaginal health could reduce this risk. However, there is little data on acceptability of intravaginal rings in SSA countries. We assessed uptake and acceptability of a contraceptive vaginal ring (CVR) among women with BV.
Methods We conducted a prospective study among women aged 18-40 years in Thika, Kenya. Participants were recruited from community venues and public health facilities. If interested and eligible, they were randomised to cyclical or continuous use of the CVR at month 1 visit and were followed up monthly for 7 months. At follow-up visits behavioural data was obtained and pregnancy testing performed. We used univariate methods to determine CVR uptake and survival methods to determine time to incident pregnancy.
Results Between April to December 2016, 363 women screened, 101 enrolled and 79 (78.2%) initiated CVR at randomization visit, 12 (11.9%) did not return for randomization and were considered lost to follow-up, 7 (6.9%) expressly refused to use CVR, and 3 (3.0%) terminated due to investigator's decision or other reasons. Reasons for refusal included lack of a stable partner, need to consult partners, and preference for other contraceptive methods. We observed 4 incident pregnancies, at an incidence of 18.7 per 100 person-years (95% CI 5.1-48.0). Conclusions Contraceptive vaginal ring was highly acceptable among women with BV with few incident pregnancies, suggesting that combination prevention with antiretrovirals using this delivery system should be feasible for this population.
